{"id":225961,"date":"2020-03-13T08:41:30","date_gmt":"2020-03-13T12:41:30","guid":{"rendered":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/cannabis-countdown-top-10-marijuana-stock-news-stories-of-the-week-marketwatch\/"},"modified":"2020-03-13T08:41:30","modified_gmt":"2020-03-13T12:41:30","slug":"cannabis-countdown-top-10-marijuana-stock-news-stories-of-the-week-marketwatch","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/psychedelics\/cannabis-countdown-top-10-marijuana-stock-news-stories-of-the-week-marketwatch\/","title":{"rendered":"Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week &#8211; MarketWatch"},"content":{"rendered":"<p><p>Welcome to theCannabis Countdown. In this weeks rendition, well recap and countdown the top 10 Marijuana Stock News stories for the week of March 2nd  8th, 2020.<\/p>\n<p>Without further ado,lets get started.<\/p>\n<p>*Yahoo Finance readers, please click here to view full article.<\/p>\n<p>The Psychedelics Industry is Beginning to Heat Up, Giving Cannabis Investors an Eerie Sense of Dja Vu<\/p>\n<p>Psychedelic Stocksare in high demand asChampignon Brands (cse:SHRM)andMindMed (neo:MMED)IPO in the same week. Lets compareSHRMandMMEDs first week of trading to see how the two stacked up and which stock came out on top.<\/p>\n<p>READ FULL PSYCHEDELIC STOCKS IPO ARTICLE<\/p>\n<p>Dow Jones Soars 1,173 Points as Joe Bidens Super Tuesday Win Sparks Major Market Rally<\/p>\n<p>As the stock market soared, North AmericanPot Stocksalso rebounded sharply with some posting double-digit gains on the day. Here are the top 15 gainers of the trading session.<\/p>\n<p>READ FULL TCI MARKET WATCH ARTICLE<\/p>\n<p>Heres What Wall Street Is Saying About TLRYs Disappointing Q4 Results<\/p>\n<p>Tilray Inc        TLRY,         -16.07%      reported a net loss of $219.1 million in the quarter, or $2.14 a share. The net loss included a $112 million impairment charge related to assets, as well as a $68 million inventory write-down.Wall Streethad been anticipating a loss of 40 cents a share.<\/p>\n<p>READ FULL TILRAY EARNINGS ARTICLE<\/p>\n<p>Now Listed on the NEO, MMED Stock Was Very Active on its First Day, Trading Over 14 Million Shares<\/p>\n<p>Prior to going public,PsychedelicsfirmMindMed (neo:MMED)  (fra:BGHM)raised $24 million in a pre-IPO round which includedKevin OLearyand the founder and former CEO ofCanopy Growth (WEED)        CGC,         -18.20%      (fra:11L1),Bruce Linton.<\/p>\n<p>READ FULL MINDMED IPO ARTICLE<\/p>\n<p>One Harvard Economist Says the U.S. Government Loses up to $20B a Year By Keeping Cannabis Illegal<\/p>\n<p>Some experts believe that the U.S. Federal Government makes up for prohibition costs and lost tax revenue in other ways, such as by not allowing cannabis companies to write-off regular business expenses.<\/p>\n<p>READ FULL FEDS CANNABIS ARTICLE<\/p>\n<p>Analysts Gordon Johnson Calls the Companys Guidance Aspirational<\/p>\n<p>GLJ Research is zeroing out itsTilray Inc        TLRY,         -16.07%      price target in the wake of the cannabis companys fourth-quarterearnings. Johnson maintained a Sell rating and lowered the price target for Tilray from $5 to $0, suggesting the equity is essentially worthless.<\/p>\n<p>READ FULL TILRAY TARGET ARTICLE<\/p>\n<p>Q4 Results Fell Short for Acreage Holdings According to Beacon Securities Analyst Russell Stanley<\/p>\n<p>In an update to clients, Stanley kept his Buy rating on shares ofAcreage Holdings (cse:ACRG.U) (otcqx:ACRGF) (0VZ),but dropped his price target from $17.00 to $5.25 per share. Stanley said the quarter came in under his estimates.<\/p>\n<p>READ FULL ACREAGE HOLDINGS ARTICLE<\/p>\n<p>BlueKudu is a Producer of Premium Edible Cannabis Products<\/p>\n<p>Curaleaf Holdings (cse:CURA) (otcqx:CURLF)will acquire BlueKudu, a Colorado-based producer of premium cannabis chocolates and gummies. Founded in 2011, BlueKudu is one of Colorados oldest and most experienced edible manufacturers.<\/p>\n<p>READ FULL CURALEAF ARTICLE<\/p>\n<p>GW Pharma Owns a Proprietary Cannabinoid Platform with Epidiolex as its Lead Product<\/p>\n<p>As the worlds first company to commercialize a plant-based cannabinoid-derived pharmaceutical,GW Pharmaceuticals        GWPH,         -11.95%      stands out as a Top Pick for 2020, according to David M. Kideckel, an analyst for AltaCorp Capital, who stayed bullish on the name in an update to clients.<\/p>\n<p>READ FULL GW PHARMA ARTICLE<\/p>\n<p>Hundreds of Canopy Employees Showed Up for Work Only to Find Themselves Out of a Job<\/p>\n<p>Canopy Growth (WEED)        CGC,         -18.20%      (fra:11L1)has closed large greenhouses in Delta and Aldergrove, B.C. The top Canadianlicensed producer (LP)says the closures have resulted in the elimination of approximately 500 positions. In addition to the closures in B.C., the company says it no longer plans to open a third greenhouse in Niagara-on-the-Lake, Ontario.<\/p>\n<p>READ FULL CANOPY BC TWEED ARTICLE<\/p>\n<p>Image Sourced from PIxabay<\/p>\n<p> 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Originally posted here: <\/p>\n<p><a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"https:\/\/www.marketwatch.com\/story\/cannabis-countdown-top-10-marijuana-stock-news-stories-of-the-week-2020-03-09?mod=exchange-traded-funds\" title=\"Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week - MarketWatch\">Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week - MarketWatch<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Welcome to theCannabis Countdown. In this weeks rendition, well recap and countdown the top 10 Marijuana Stock News stories for the week of March 2nd 8th, 2020. Without further ado,lets get started <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/psychedelics\/cannabis-countdown-top-10-marijuana-stock-news-stories-of-the-week-marketwatch\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[187761],"tags":[],"class_list":["post-225961","post","type-post","status-publish","format-standard","hentry","category-psychedelics"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/225961"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=225961"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/225961\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=225961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=225961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=225961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}